Revenue grew 11.4% to $209.3M in 2026Q3 and operating margin improved to -3.8% from -26.3% in 2025Q2, though profitability remains negative with a $7.9M operating loss.
NeoGenomics, Inc. (NEO) annual income statement — 26-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 |
|---|
| Sales/Revenue | 787.75M | 727.33M | 660.57M | 591.64M | 509.73M | 484.33M | 444.45M | 408.83M | 276.74M | 240.25M | 244.08M | 99.8M | 87.07M | 66.47M | 59.87M | 43.48M | 34.37M | 29.47M | 20.02M | 11.51M | 6.48M | 1.89M | 558.07K | 369.97K | 93.49K | 1K | 252.4K |
| Revenue Growth % | 11.08% | 10.11% | 11.65% | 16.07% | 5.24% | 8.97% | 8.71% | 47.73% | 15.19% | -1.57% | 144.57% | 14.62% | 31% | 11.02% | 37.68% | 26.51% | 16.63% | 47.23% | 73.97% | 77.66% | 243.55% | 237.77% | 50.84% | 295.73% | 9249.1% | -99.6% | - |
| Cost of Goods Sold | 442.71M | 444.79M | 370.47M | 347.04M | 321.83M | 297.27M | 258.56M | 211.99M | 149.48M | 138.29M | 133.7M | 56.05M | 46.35M | 34.73M | 33.03M | 24.06M | 18.59M | 14.25M | 9.35M | 5.52M | 2.76M | 1.19M | 576.87K | 481.59K | 189.96K | 0 | 74.29K |
| COGS % of Revenue | - | 61.15% | 56.08% | 58.66% | 63.14% | 61.38% | 58.17% | 51.85% | 54.01% | 57.56% | 54.78% | 56.16% | 53.24% | 52.25% | 55.17% | 55.32% | 54.08% | 48.37% | 46.73% | 48.01% | 42.6% | 63.02% | 103.37% | 130.17% | 203.18% | - | 29.43% |
| Gross Profit | 345.04M | 282.54M | 290.1M | 244.6M | 187.9M | 187.06M | 185.89M | 196.84M | 127.27M | 101.96M | 110.38M | 43.76M | 40.71M | 47.8K | 26.84M | 19.43M | 15.78M | 15.21M | 10.66M | 5.98M | 3.72M | 696.92K | -18.79K | -112K | -96.47K | 1K | 178.11K |
| Gross Margin % | 43.8% | 38.85% | 43.92% | 41.34% | 36.86% | 38.62% | 41.83% | 48.15% | 45.99% | 42.44% | 45.22% | 43.84% | 46.76% | 0.07% | 44.83% | 44.68% | 45.92% | 51.63% | 53.27% | 51.99% | 57.4% | 36.97% | -3.37% | -30.27% | -103.18% | 100% | 70.57% |
| Gross Profit Growth % | - | -2.61% | 18.6% | 30.18% | 0.45% | 0.63% | -5.56% | 54.67% | 24.82% | -7.63% | 152.26% | 7.47% | 85075.73% | -99.82% | 38.13% | 23.09% | 3.73% | 42.72% | 78.22% | 60.94% | 433.35% | 3808.41% | 83.22% | -16.1% | -9746.7% | -99.44% | - |
| Operating Expenses | 392.13M | 348.62M | 382.21M | 352.34M | 345.52M | 305.81M | 199.88M | 183.83M | 117.22M | 99.05M | 95.95M | 49.39M | 38.5M | 28.56M | 25.63M | 19.84M | 18.75M | 16.94M | 11.54M | 9.12M | 3.58M | 1.5M | 710.77K | 382.71K | 487.21K | 8.08M | 1.15M |
| OpEx % of Revenue | - | 47.93% | 57.86% | 59.55% | 67.78% | 63.14% | 44.97% | 44.96% | 42.36% | 41.23% | 39.31% | 49.49% | 44.21% | 42.97% | 42.8% | 45.62% | 54.54% | 57.49% | 57.68% | 79.3% | 55.23% | 79.42% | 127.36% | 103.44% | 521.13% | 807900% | 455.22% |
| Selling, General & Admin | 362.08M | 365.34M | 310.49M | 279.96M | 277.91M | 283.94M | 191.66M | 175.34M | 114.22M | 113.3M | 87.84M | 45.19M | 35.81M | 26.12M | 23.34M | 19.84M | 18.75M | 16.94M | 11.54M | 9.12M | 3.58M | 1.5M | 710.77K | 382.71K | 440.79K | 8.08M | 1.12M |
| SG&A % of Revenue | - | 50.23% | 47% | 47.32% | 54.52% | 58.63% | 43.12% | 42.89% | 41.27% | 47.16% | 35.99% | 45.28% | 41.12% | 39.3% | 38.99% | 45.62% | 54.54% | 57.49% | 57.68% | 79.3% | 55.23% | 79.42% | 127.36% | 103.44% | 471.48% | 807900% | 444.92% |
| Research & Development | 39.33M | 37.08M | 31.16M | 27.31M | 30.33M | 21.87M | 8.23M | 8.49M | 3M | 3.64M | 4.65M | 4.2M | 2.69M | 2.44M | 2.28M | 543K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46.41K | 0 | 0 |
| R&D % of Revenue | - | 5.1% | 4.72% | 4.62% | 5.95% | 4.52% | 1.85% | 2.08% | 1.08% | 1.51% | 1.9% | 4.21% | 3.09% | 3.67% | 3.81% | 1.25% | - | - | - | - | - | - | - | - | 49.65% | - | - |
| Other Operating Expenses | -1000K | -53.8M | 40.55M | 45.07M | 37.29M | 0 | 0 | 0 | 14K | 1.06M | 3.46M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26.4K |
| Operating Income | -47.09M | -66.08M | -92.11M | -107.74M | -157.62M | -118.75M | -13.99M | 13.01M | 10.04M | 2.9M | 2.57M | -5.63M | 2.22M | 3.17M | 1.21M | -409K | -2.96M | -1.73M | -884K | -3.14M | 139.99K | -800K | -730K | -494K | -584K | -8.08M | -971K |
| Operating Margin % | -5.98% | -9.09% | -13.94% | -18.21% | -30.92% | -24.52% | -3.15% | 3.18% | 3.63% | 1.21% | 1.05% | -5.65% | 2.55% | 4.78% | 2.02% | -0.94% | -8.62% | -5.86% | -4.42% | -27.3% | 2.16% | -42.44% | -130.81% | -133.52% | -624.66% | -807800% | -384.7% |
| Operating Income Growth % | - | 28.26% | 14.51% | 31.65% | -32.73% | -748.73% | -207.58% | 29.54% | 245.97% | 12.74% | 145.68% | -354.06% | -30.12% | 162.1% | 396.09% | 86.2% | -71.47% | -95.48% | 71.86% | -2343.67% | 117.5% | -9.59% | -47.77% | 15.41% | 92.77% | -731.93% | - |
| EBITDA | 18.11M | 1.75M | -19.56M | -35.15M | -88.19M | -65.4M | 21.73M | 43.28M | 31.77M | 25.49M | 25.78M | 1.51M | 7.86M | 7.59M | 5.03M | 1.68M | -1.18M | -544K | -143.44K | -2.63M | 446.58K | -618.93K | -625.74K | -445.96K | -791K | -7.83M | -944.6K |
| EBITDA Margin % | 2.3% | 0.24% | -2.96% | -5.94% | -17.3% | -13.5% | 4.89% | 10.59% | 11.48% | 10.61% | 10.56% | 1.51% | 9.03% | 11.41% | 8.4% | 3.85% | -3.44% | -1.85% | -0.72% | -22.9% | 6.9% | -32.83% | -112.12% | -120.54% | -846.07% | -783232.9% | -374.24% |
| EBITDA Growth % | 135.34% | 108.92% | 44.36% | 60.14% | -34.85% | -400.99% | -49.79% | 36.21% | 24.63% | -1.12% | 1610.88% | -80.82% | 3.59% | 50.85% | 200.06% | 241.79% | -117.28% | -279.26% | 94.56% | -689.96% | 172.15% | 1.09% | -40.31% | 43.62% | 89.9% | -729.17% | - |
| D&A (Non-Cash Add-back) | 65.21M | 67.82M | 72.55M | 72.58M | 69.43M | 53.35M | 35.72M | 30.27M | 21.73M | 22.59M | 23.21M | 7.14M | 5.64M | 4.41M | 3.82M | 2.08M | 1.78M | 1.18M | 740.56K | 506.36K | 306.59K | 181.07K | 104.26K | 48.04K | -207K | 245.67K | 26.4K |
| EBIT | -32.93M | -106.52M | -74.06M | -90.19M | -151.76M | -6.86M | -7.04M | 7.36M | 10.04M | 3.96M | 2.15M | -3.63M | 2.22M | 3.17M | 1.21M | -409K | -2.96M | -1.73M | -884K | -3.14M | 139.99K | -800K | -730K | -494K | -584K | -8.08M | -971K |
| Net Interest Income | 1.96M | 5.32M | 11.81M | 9.99M | -1.51M | -5.08M | -7.02M | -3.71M | -6.23M | -5.54M | -10M | -854K | -985K | -989K | -1.15M | -768K | -710K | -532K | -309K | 0 | -326K | -197K | 0 | -41.43K | 0 | 0 | 0 |
| Interest Income | 5.21M | 9.07M | 18.43M | 16.9M | 6.08M | 3.14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 3.25M | 3.75M | 6.62M | 6.91M | 7.58M | 8.22M | 7.02M | 3.71M | 6.23M | 5.54M | 10M | 854K | 985K | 989K | 1.15M | 768K | 710K | 532.39K | 308.52K | 0 | 325.63K | 196.8K | 0 | 41.43K | 207.31K | 0 | 0 |
| Other Income/Expense | 10.91M | -44.19M | 11.43M | 10.64M | -1.72M | 103.68M | -64K | -9.36M | -6.22M | -5.55M | -10M | 1.15M | -929K | -989K | -1.15M | -768K | -1K | 0 | -499K | -239K | -140K | -197K | -89.42K | 0 | 0 | 0 | 646 |
| Pretax Income | -36.18M | -110.27M | -80.67M | -97.1M | -159.34M | -15.07M | -14.06M | 3.65M | 3.82M | -2.65M | -7.42M | -4.49M | 1.29M | 2.19M | 65K | -2.7K | -3.3M | -2.24M | -1.07M | -3.12M | -130K | -997K | -819K | 0 | 0 | 0 | -970K |
| Pretax Margin % | -4.59% | -15.16% | -12.21% | -16.41% | -31.26% | -3.11% | -3.16% | 0.89% | 1.38% | -1.1% | -3.04% | -4.5% | 1.48% | 3.29% | 0.11% | -0.01% | -9.61% | -7.61% | -5.37% | -27.09% | -2.01% | -52.89% | -146.75% | - | - | - | -384.31% |
| Income Tax | -3.88M | -2.24M | -1.95M | -9.13M | -15.09M | -6.73M | -18.23M | -4.36M | 1.18M | -2.25M | -1.7M | -1.95M | 157K | 152K | 0 | 768K | -740K | -34.18K | 180.15K | 214.94K | -112K | 0 | 0 | 41.43K | 214.16K | 0 | -1.29K |
| Effective Tax Rate % | 10.74% | 2.03% | 2.42% | 9.4% | 9.47% | 44.63% | 129.68% | -119.64% | 30.96% | 85.06% | 22.91% | 43.53% | 12.18% | 6.96% | 0% | -28444.44% | 22.4% | 1.52% | -16.77% | -6.9% | 86.15% | 0% | 0% | - | - | - | 0.13% |
| Net Income | -32.3M | -108.03M | -78.73M | -87.97M | -144.25M | -8.35M | 4.17M | 8.01M | 2.64M | -396K | -6.14M | -2.54M | 1.13M | 2.03M | 65K | -1.18M | -3.3M | -2.24M | -1.38M | -3.38M | -130K | -997K | -819K | -536K | -591K | -8.08M | -970K |
| Net Margin % | -4.1% | -14.85% | -11.92% | -14.87% | -28.3% | -1.72% | 0.94% | 1.96% | 0.95% | -0.16% | -2.52% | -2.54% | 1.3% | 3.06% | 0.11% | -2.71% | -9.61% | -7.61% | -6.91% | -29.38% | -2.01% | -52.89% | -146.75% | -144.88% | -632.15% | -807800% | -384.31% |
| Net Income Growth % | 71.54% | -37.22% | 10.51% | 39.02% | -1628.17% | -300.07% | -47.89% | 203.26% | 766.67% | 93.55% | -142.29% | -323.94% | -44.32% | 3027.69% | 105.52% | 64.37% | -47.26% | -62.18% | 59.08% | -2500% | 86.96% | -21.73% | -52.8% | 9.31% | 92.68% | -732.78% | - |
| Net Income (Continuing) | -32.3M | -108.03M | -78.73M | -87.97M | -144.25M | -8.35M | 4.17M | 8.01M | 2.64M | -396K | -5.72M | -2.54M | 1.13M | 2.03M | 65K | -1.18M | -3.3M | -2.24M | -1.38M | -3.38M | -130K | -997K | -819K | -536K | -591K | -8.08M | -970K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.25 | -0.84 | -0.62 | -0.70 | -1.16 | -0.07 | 0.04 | 0.08 | 0.03 | -0.01 | -0.08 | -0.21 | 0.10 | 0.20 | 0.01 | -0.14 | -0.44 | -0.32 | -0.22 | -0.55 | -0.03 | -0.22 | -0.20 | -0.19 | -0.70 | -10.70 | -6.20 |
| EPS Growth % | 71.95% | -35.48% | 11.43% | 39.66% | -1566.67% | -286.6% | -51.75% | 168.4% | - | 93.69% | 62.29% | -310% | -50% | - | 104.64% | 68.18% | -37.5% | -45.45% | 60% | -2100% | 88.64% | -10% | -5.26% | 72.86% | 93.46% | -72.58% | - |
| EPS (Basic) | - | -0.84 | -0.62 | -0.70 | -1.16 | -0.07 | 0.04 | 0.08 | 0.03 | -0.01 | -0.08 | -0.21 | 0.10 | 0.20 | 0.01 | -0.14 | -0.44 | -0.32 | -0.22 | -0.55 | -0.03 | -0.22 | -0.20 | -0.19 | -0.70 | -2.15 | -1.25 |
| Diluted Shares Outstanding | 128.59M | 128.1M | 126.66M | 125.5M | 124.22M | 119.96M | 111.79M | 103.61M | 91.57M | 79.43M | 77.54M | 12.11M | 11.2M | 10.55M | 9.74M | 8.55M | 7.47M | 6.93M | 6.3M | 6.27M | 5.23M | 4.51M | 4.16M | 2.88M | 857.6K | 754.2K | 156.4K |
| Basic Shares Outstanding | 128.59M | 128.1M | 126.66M | 125.5M | 124.22M | 119.96M | 108.58M | 100.47M | 91.57M | 79.43M | 77.54M | 12.11M | 11.32M | 10.16M | 9.75M | 8.55M | 7.47M | 6.93M | 6.3M | 6.27M | 5.23M | 4.51M | 4.16M | 2.88M | 857.6K | 3.77M | 782K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quick answers to the most common questions about buying NEO stock.
For fiscal year 2025, NeoGenomics, Inc. (NEO) reported total revenue of $727.3M. This represents a 288063.0% increase compared to $0.3M in 2000.
NeoGenomics, Inc. (NEO) reported a net loss of $108.0M for the fiscal year ending 2025.
NeoGenomics, Inc. (NEO) reported an operating income of $-66.1M, resulting in an operating profit margin of -9.1%. This margin reflects the operational efficiency of the business before interest and taxes.
NeoGenomics, Inc. (NEO) generated $282.5M in gross profit for the year, representing a gross profit margin of 38.8%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Persistent operating losses at scale
Metrics are mathematically derived from official filings.
Steady Double-Digit Top-Line Expansion Persists
Based on reported income statement figures, NEO's revenue grew 11.4% year over year to $209.3M in the latest quarter, indicating durable demand despite a sequential slowdown in the 7.5% to 12% range seen across recent periods.
The revenue series shows consistent expansion from $164.5M in 2024Q2 to $209.3M in 2026Q3, with year-over-year growth clustering around 10% to 12% for most of the window. This pattern suggests volume-driven demand rather than a single pricing event, though the reported figures do not allow separation of volume from price effects. Investors should monitor whether growth sustains at this rate, since the 2025Q1 dip to 7.5% warranted attention.
Gross Margin Recovery Lags Revenue Growth
As reported in financial statements, NEO's gross margin rebounded from a 39.8% low in 2025Q4 to 46.2% in 2026Q3, yet remains below the 44.9% to 46.2% range management's pricing trajectory would need to fully offset fixed costs.
Gross margin moved within a relatively narrow band of roughly 40% to 46% over the period, with the 2025Q4 trough suggesting sensitivity to cost of goods sold timing or mix. The recent recovery to 46.2% indicates improving unit economics, but the reported data does not isolate pricing power relative to peers. Peer gross margins in the supplied set range widely, so the comparison is limited by differing business models.
Operating Leverage Remains Negative Despite Scale
Based on NEO's reported figures, operating margin improved from -26.3% in 2025Q2 to -3.8% in 2026Q3, suggesting operating income is beginning to scale faster than revenue as SG&A held near $90M to $95M.
SG&A stayed roughly flat in the $85M to $96M range while revenue grew about 25% across the window, which is the core source of margin improvement. This suggests overhead efficiency is emerging, though the company has not yet reached operating breakeven on a sustained basis. The narrowing loss implies operating leverage is working in the right direction but has not yet proven durable.
Reported Profit Volatile and Share-Count Sensitive
According to reported filings, NEO's diluted EPS swung from -$1.75 in 2025Q2 to +$0.02 in 2026Q2 before returning to -$0.06, a pattern that may reflect non-operating items and share-count effects rather than steady earnings power.
Net income turned positive in 2026Q2 at $2.2M while operating income remained negative, suggesting non-operating items or tax effects contributed to that quarter. Stock-based compensation of $8M to $12M per quarter represents a material cost that may depress reported earnings quality relative to cash-based measures. The volatility warrants further investigation before treating any single quarter as a reliable earnings signal.
Margin Recovery May Stall at Current Levels
Based on reported figures, the bear case centers on whether NEO's operating loss of $7.9M in 2026Q3 can close, since revenue growth alone has not produced sustained profitability over ten quarters of reported data.
Operating losses have persisted in every quarter of the supplied history, and the latest quarter's operating margin of -3.8% still implies cost structure gaps. Short-side analysis would argue that SG&A growth of $94.7M against revenue growth may limit leverage if top-line growth decelerates. Investors should monitor whether gross margin can hold above 45% while SG&A stays flat, since failure on either front would extend the loss period.